Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8033.63%
operating margin TTM
-8572.12%
revenue TTM
226.24 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -1.15 |
| peg ratio | -0.51 |
| price to book ratio | 3.48 |
| price to sales ratio | 92.50 |
| enterprise value multiple | -1.93 |
| price fair value | 3.48 |
profitability ratios | |
|---|---|
| gross profit margin | 90.71% |
| operating profit margin | -8572.12% |
| pretax profit margin | -8033.63% |
| net profit margin | -8033.63% |
| return on assets | -99.91% |
| return on equity | -144.95% |
| return on capital employed | -221.41% |
liquidity ratio | |
|---|---|
| current ratio | 1.93 |
| quick ratio | 1.77 |
| cash ratio | 1.74 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 25,758.57 |
| operating cycle | 25,787.64 |
| days of payables outstanding | 114,158.10 |
| cash conversion cycle | -88,370.45 |
| receivables turnover | 12.56 |
| payables turnover | 0.00 |
| inventory turnover | 0.01 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -53.52 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -666.14 |
| cash per share | 0.78 |
| operating cash flow per share | -0.85 |
| free cash flow operating cash flow ratio | 786.94 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -0.00 |
Frequently Asked Questions
When was the last time Onconova Therapeutics, Inc. (NASDAQ:ONTX) reported earnings?
Onconova Therapeutics, Inc. (ONTX) published its most recent earnings results on 15-05-2024.
What is Onconova Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Onconova Therapeutics, Inc. (NASDAQ:ONTX)'s trailing twelve months ROE is -144.95%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Onconova Therapeutics, Inc. (ONTX) currently has a ROA of -99.91%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ONTX's net profit margin stand at?
ONTX reported a profit margin of -8033.63% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ONTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.93 in the most recent quarter. The quick ratio stood at 1.77, with a Debt/Eq ratio of 0.00.